• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风湿性心脏病疫苗接种:当前研究策略和挑战的综述。

Vaccination against rheumatic heart disease: a review of current research strategies and challenges.

机构信息

Institute for Glycomics, Griffith University, G26/4.30 Gold Coast Campus, Gold Coast, QLD, 4222, Australia,

出版信息

Curr Infect Dis Rep. 2012 Aug;14(4):381-90. doi: 10.1007/s11908-012-0263-7.

DOI:10.1007/s11908-012-0263-7
PMID:22729401
Abstract

Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are major health problems in many developing countries and Indigenous populations of developed countries. ARF and RHD are sequelae resulting from an infection of Streptococcus pyogenes. Despite advances in health care practices and technology, these diseases still pose major challenges in the communities where Streptococcus pyogenes is often endemic. Here we review and discuss the dynamic epidemiology of streptococcal infection and its associated diseases (ARF and RHD), with a focus on disease burden in temperate versus tropical regions, the tissue tropism of the organism and the efforts towards vaccine development in relation to the available animal models.

摘要

急性风湿热(ARF)和风湿性心脏病(RHD)是许多发展中国家和发达国家土著居民的主要健康问题。ARF 和 RHD 是由化脓性链球菌感染引起的后遗症。尽管医疗保健实践和技术取得了进步,但这些疾病在链球菌常流行的社区仍然构成重大挑战。在这里,我们回顾和讨论链球菌感染及其相关疾病(ARF 和 RHD)的动态流行病学,重点讨论温带与热带地区的疾病负担、病原体的组织嗜性以及与现有动物模型相关的疫苗开发工作。

相似文献

1
Vaccination against rheumatic heart disease: a review of current research strategies and challenges.风湿性心脏病疫苗接种:当前研究策略和挑战的综述。
Curr Infect Dis Rep. 2012 Aug;14(4):381-90. doi: 10.1007/s11908-012-0263-7.
2
Rheumatic heart disease: A review of the current status of global research activity.风湿性心脏病:全球研究活动现状综述。
Autoimmun Rev. 2021 Feb;20(2):102740. doi: 10.1016/j.autrev.2020.102740. Epub 2020 Dec 14.
3
The rise and fall of acute rheumatic fever and rheumatic heart disease: a mini review.急性风湿热和风湿性心脏病的兴衰:一篇综述短文
Front Cardiovasc Med. 2023 May 23;10:1183606. doi: 10.3389/fcvm.2023.1183606. eCollection 2023.
4
Controlling acute rheumatic fever and rheumatic heart disease in developing countries: are we getting closer?在发展中国家控制急性风湿热和风湿性心脏病:我们正在接近目标吗?
Curr Opin Pediatr. 2015 Feb;27(1):116-23. doi: 10.1097/MOP.0000000000000164.
5
Unveiling the Group A Streptococcus Vaccine-Based L-Rhamnose from Backbone of Group A Carbohydrate: Current Insight Against Acute Rheumatic Fever to Reduce the Global Burden of Rheumatic Heart Disease.从A群碳水化合物主链中揭示基于A群链球菌疫苗的L-鼠李糖:当前对急性风湿热的认识,以减轻风湿性心脏病的全球负担。
F1000Res. 2025 Jan 30;13:132. doi: 10.12688/f1000research.144903.3. eCollection 2024.
6
Acute rheumatic fever: a chink in the chain that links the heart to the throat?急性风湿热:连接心脏与咽喉的链条上的一个缺口?
Lancet Infect Dis. 2004 Apr;4(4):240-5. doi: 10.1016/S1473-3099(04)00975-2.
7
IgG2 rules: N-acetyl-β-D-glucosamine-specific IgG2 and Th17/Th1 cooperation may promote the pathogenesis of acute rheumatic heart disease and be a biomarker of the autoimmune sequelae of .IgG2 规则:N-乙酰-β-D-葡萄糖胺特异性 IgG2 与 Th17/Th1 协同作用可能促进急性风湿性心脏病的发病机制,并且是其自身免疫后遗症的生物标志物。
Front Cardiovasc Med. 2023 Feb 6;9:919700. doi: 10.3389/fcvm.2022.919700. eCollection 2022.
8
Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart disease.低剂量白细胞介素2疗法可阻止风湿性心脏病大鼠模型中链球菌感染后自身免疫并发症的进展。
mBio. 2025 Apr 9;16(4):e0382324. doi: 10.1128/mbio.03823-24. Epub 2025 Feb 25.
9
Contemporary Incidence and Prevalence of Rheumatic Fever and Rheumatic Heart Disease in Australia Using Linked Data: The Case for Policy Change.利用关联数据评估澳大利亚风湿热和风湿性心脏病的当代发病率和流行率:政策改革势在必行。
J Am Heart Assoc. 2020 Oct 20;9(19):e016851. doi: 10.1161/JAHA.120.016851. Epub 2020 Sep 14.
10
A mini review of the pathogenesis of acute rheumatic fever and rheumatic heart disease.急性风湿热和风湿性心脏病发病机制的简要综述。
Front Cell Infect Microbiol. 2025 Apr 10;15:1447149. doi: 10.3389/fcimb.2025.1447149. eCollection 2025.

引用本文的文献

1
Tonsils at Telethon: developing a standardised collection of tonsil photographs for group A streptococcal (GAS) research.“爱心马拉松”活动中的扁桃体:为A组链球菌(GAS)研究开发标准化的扁桃体照片集。
Front Pediatr. 2024 Apr 25;12:1367060. doi: 10.3389/fped.2024.1367060. eCollection 2024.
2
A pilot study to develop assessment tools for Group A Streptococcus surveillance studies.一项用于开发 A 组链球菌监测研究评估工具的初步研究。
PeerJ. 2023 Mar 14;11:e14945. doi: 10.7717/peerj.14945. eCollection 2023.
3
Health system and patient-level factors serving as facilitators and barriers to rheumatic heart disease care in Sudan.

本文引用的文献

1
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.新型 30 价 M 蛋白疫苗引发针对 A 组链球菌非疫苗血清型的交叉调理抗体。
Vaccine. 2011 Oct 26;29(46):8175-8. doi: 10.1016/j.vaccine.2011.09.005. Epub 2011 Sep 13.
2
Human pathogenic streptococcal proteomics and vaccine development.人病原性链球菌蛋白质组学与疫苗开发。
Proteomics Clin Appl. 2008 Mar;2(3):387-410. doi: 10.1002/prca.200780048.
3
Hemolytic streptococcus sore throat; detailed study of the simultaneous infection of a large number of men by a single type.
苏丹风湿性心脏病护理的卫生系统和患者层面的促进和阻碍因素。
Glob Health Res Policy. 2021 Oct 2;6(1):35. doi: 10.1186/s41256-021-00222-2.
4
Molecular Epidemiology, Ecology, and Evolution of Group A Streptococci.A 组链球菌的分子流行病学、生态学和进化。
Microbiol Spectr. 2018 Sep;6(5). doi: 10.1128/microbiolspec.CPP3-0009-2018.
5
Towards developing a vaccine for rheumatic heart disease.致力于研发一种用于风湿性心脏病的疫苗。
Glob Cardiol Sci Pract. 2017 Mar 31;2017(1):e201704. doi: 10.21542/gcsp.2017.4.
6
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models.A群链球菌候选疫苗和全长M蛋白在皮肤和侵袭性疾病模型中的不同疗效
mBio. 2016 Jun 14;7(3):e00618-16. doi: 10.1128/mBio.00618-16.
7
StreptInCor: a model of anti-Streptococcus pyogenes vaccine reviewed.抗化脓性链球菌疫苗模型StreptInCor综述。
Auto Immun Highlights. 2013 Oct 4;4(3):81-5. doi: 10.1007/s13317-013-0053-8. eCollection 2013 Dec.
8
The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design.A群链球菌的经典兰斯菲尔德抗原是一种毒力决定因素,对疫苗设计具有重要意义。
Cell Host Microbe. 2014 Jun 11;15(6):729-740. doi: 10.1016/j.chom.2014.05.009.
9
Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease.世界心脏联合会关于预防和控制风湿性心脏病的立场声明。
Nat Rev Cardiol. 2013 May;10(5):284-92. doi: 10.1038/nrcardio.2013.34. Epub 2013 Apr 2.
溶血性链球菌性咽喉炎;对大量男性同时感染单一类型病菌的详细研究。
Arch Intern Med (Chic). 1945 Nov-Dec;76:278-83. doi: 10.1001/archinte.1945.00210350024004.
4
Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever.大洋洲新喀里多尼亚地区(急性风湿热高发地区)侵袭性化脓性链球菌病的临床和微生物学特征。
J Clin Microbiol. 2010 Feb;48(2):526-30. doi: 10.1128/JCM.01205-09. Epub 2009 Dec 2.
5
ANTIGENIC DIFFERENCES BETWEEN MATT HEMOLYTIC STREPTOCOCCI AND THEIR GLOSSY VARIANTS.马型溶血性链球菌与其光滑变异株之间的抗原差异。
J Exp Med. 1928 Nov 30;48(6):769-90. doi: 10.1084/jem.48.6.769.
6
Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children.由无乳链球菌(G 组和 C 组链球菌)引起的疾病负担高于酿脓链球菌在孟买学童中引起的疾病负担。
J Med Microbiol. 2010 Feb;59(Pt 2):220-223. doi: 10.1099/jmm.0.015644-0. Epub 2009 Oct 15.
7
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.A群链球菌的全球emm型分布:系统评价及对疫苗研发的启示
Lancet Infect Dis. 2009 Oct;9(10):611-6. doi: 10.1016/S1473-3099(09)70178-1.
8
A vaccine against S. pyogenes: design and experimental immune response.抗酿脓链球菌疫苗的设计与实验免疫应答。
Methods. 2009 Dec;49(4):316-21. doi: 10.1016/j.ymeth.2009.03.024. Epub 2009 May 4.
9
Mechanism of protection induced by group A Streptococcus vaccine candidate J8-DT: contribution of B and T-cells towards protection.A群链球菌候选疫苗J8-DT诱导的保护机制:B细胞和T细胞对保护作用的贡献
PLoS One. 2009;4(4):e5147. doi: 10.1371/journal.pone.0005147. Epub 2009 Apr 2.
10
Vaccine based on a ubiquitous cysteinyl protease and streptococcal pyrogenic exotoxin A protects against Streptococcus pyogenes sepsis and toxic shock.基于一种普遍存在的半胱氨酸蛋白酶和链球菌致热外毒素A的疫苗可预防化脓性链球菌败血症和中毒性休克。
J Immune Based Ther Vaccines. 2008 Oct 31;6:8. doi: 10.1186/1476-8518-6-8.